Mohit Pahuja, MD
Interventional Cardiology · Oklahoma City, OKNPI 1548675325
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $13,489 of the $21,097 with a category attached, or 63.9%. It is spread thinly across 40 manufacturers, the largest accounting for just 23.0%.
Across 440 payments — averaging $47.95 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$5K
- Medtronic$3K
- Abiomed$3K
- Boston Scientific$2K
- Edwards Lifesciences$2K
- W. L. Gore & Associates, Inc.$1K
- plus $6K from 34 others
Across 1 payment — averaging $27.87 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Abiomed$28
What the payments were for
- Consulting fees$6303%
- Travel & lodging$6,77532%
- Food & beverage$13,48964%
- Education$2041%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 46 | $4,855 |
| Medtronic(2 entities) | 46 | $2,753 |
| Abiomed | 29 | $2,515 |
| Boston Scientific | 136 | $1,920 |
| Edwards Lifesciences | 25 | $1,725 |
| W. L. Gore & Associates, Inc. | 19 | $1,374 |
| Philips North America LLC | 7 | $1,014 |
| Shockwave Medical, Inc | 13 | $1,001 |
| E.r. Squibb & Sons, L.L.C. | 25 | $675 |
| Alnylam Pharmaceuticals Inc. | 3 | $665 |
| Angiodynamics, Inc. | 4 | $321 |
| Pfizer | 12 | $274 |
| Getinge USA Sales, LLC | 5 | $227 |
| Inari Medical, Inc. | 10 | $204 |
| Teleflex LLC | 8 | $193 |
| Novartis | 8 | $149 |
| Cook Medical LLC | 1 | $138 |
| Amgen | 3 | $123 |
| Cardiovascular Systems Inc. | 1 | $117 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 3 | $112 |
| Pulmonx Corporation | 2 | $79 |
| Novo Nordisk | 4 | $77 |
| Baxter Healthcare | 2 | $75 |
| Biotronik Inc. | 5 | $65 |
| Stryker | 3 | $60 |
| Kestra Medical Technology Services, Inc. | 3 | $59 |
| BD | 1 | $40 |
| AstraZeneca | 2 | $34 |
| Cardiva Medical, Inc. | 2 | $32 |
| Chiesi USA, Inc. | 2 | $31 |
| Livanova USA, Inc. | 1 | $24 |
| Merck | 1 | $23 |
| Atricure, Inc. | 1 | $23 |
| Surmodics, Inc. | 1 | $21 |
| Impulse Dynamics (USA) Inc. | 1 | $20 |
| Johnson & Johnson | 1 | $20 |
| Cashflow Solutions, LLC | 1 | $16 |
| La Jolla Pharmaceutical Company | 1 | $14 |
| Irhythm Technologies, Inc. | 1 | $14 |
| Bard Peripheral Vascular, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- THORATEC HEARTMATE 3 LVAS IMPLANT KIT$1,872
- Impella$1,813
- HARMONY$1,162
- Ensite Cardiac Mapping System$1,112
- Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter$891
- (6361) Core Mobile$746
- GORE CARDIOFORM Septal Occluder$717
- Edwards SAPIEN 3 Transcatheter Heart Valve$422
- COREVALVE EVOLUT R$381
- CAMZYOS$249
- GENERAL VASCULAR ACCESS$186
- AMPLATZER Occluders$176
- OPTICROSS$150
- XIENCE SKYPOINT$146
- COROFLOW$144
- DRAGONFLY OPSTAR$144
- GENERAL - THERAPIES$141
- EchoTip$138
- IGT D Coronary$129
- AlphaVac$123
How this compares
$21,097 in reported general payments places this provider in the 80th percentile of 110 interventional cardiology providers in Oklahoma.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EntrestoSacubitril/Valsartan | 82 | $118,824 |
| JardianceEmpagliflozin | 69 | $70,439 |
| EliquisApixaban | 50 | $43,804 |
| FarxigaDapagliflozin Propanediol | 32 | $34,333 |
| BrilintaTicagrelor | 37 | $17,167 |
| Metoprolol Succinate | 135 | $1,371 |
| Atorvastatin Calcium | 89 | $720 |
| Spironolactone | 77 | $573 |
| Carvedilol | 87 | $503 |
| Furosemide | 91 | $440 |
| Lisinopril | 53 | $403 |
| Isosorbide Mononitrate ErIsosorbide Mononitrate | 32 | $357 |
| ClopidogrelClopidogrel Bisulfate | 17 | $310 |
| Rosuvastatin Calcium | 20 | $235 |
| Torsemide | 18 | $202 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| NovartisEntresto | $149 | $118,82482 claims |
| AstraZenecaFarxiga, Brilinta | $34 | $51,50069 claims |
| PfizerEliquis | $274 | $43,80450 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 110 interventional cardiology providers in Oklahoma.
Other interventional cardiology in Oklahoma City
- George ChrysantOklahoma City$524K
- Jeffrey SparlingOklahoma City$231K
- Thomas McGarryOklahoma City$80K
- Usman BaberOklahoma City$76K
- Marcus SmithOklahoma City$67K
- Parker TruongOklahoma City$44K
- Mohammad GhaniOklahoma City$38K
- Timothy DalyOklahoma City$31K
- Branislav SchifferdeckerOklahoma City$26K
- Syed AliOklahoma City$19K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.